Preface
Immunotherapy & thoracic cancers
Journal of Thoracic Disease
2018;
10
(Suppl 13)
:S1425-S1426
.
(29 May 2018)
Review Article
Is there a room for immune checkpoint inhibitors in early stage non-small cell lung cancer?
Journal of Thoracic Disease
2018;
10
(Suppl 13)
:S1427-S1437
.
(29 May 2018)
The role of radiology in the evaluation of the immunotherapy efficacy
Journal of Thoracic Disease
2018;
10
(Suppl 13)
:S1438-S1446
.
(29 May 2018)
Combining immunotherapy and radiotherapy in lung cancer
Journal of Thoracic Disease
2018;
10
(Suppl 13)
:S1447-S1460
.
(29 May 2018)
Locally-advanced non-small cell lung cancer: shall immunotherapy be a new chance?
Journal of Thoracic Disease
2018;
10
(Suppl 13)
:S1461-S1467
.
(29 May 2018)
Advanced non-small cell lung cancer: the role of PD-L1 inhibitors
Journal of Thoracic Disease
2018;
10
(Suppl 13)
:S1468-S1473
.
(29 May 2018)
Lung cancer, elderly and immune checkpoint inhibitors
Journal of Thoracic Disease
2018;
10
(Suppl 13)
:S1474-S1481
.
(29 May 2018)
Immunotherapy in the Asiatic population: any differences from Caucasian population?
Journal of Thoracic Disease
2018;
10
(Suppl 13)
:S1482-S1493
.
(29 May 2018)
Immune checkpoint blockade for advanced non-small cell lung cancer: challenging clinical scenarios
Journal of Thoracic Disease
2018;
10
(Suppl 13)
:S1494-S1502
.
(29 May 2018)
Immune checkpoint inhibitors and small cell lung cancer: what’s new?
Journal of Thoracic Disease
2018;
10
(Suppl 13)
:S1503-S1508
.
(29 May 2018)
Thymic tumors and immune checkpoint inhibitors
Journal of Thoracic Disease
2018;
10
(Suppl 13)
:S1509-S1515
.
(29 May 2018)
Immune-related adverse events with immune checkpoint inhibitors in thoracic malignancies: focusing on non-small cell lung cancer patients
Journal of Thoracic Disease
2018;
10
(Suppl 13)
:S1516-S1533
.
(29 May 2018)
Shining light on advanced NSCLC in 2017: combining immune checkpoint inhibitors
Journal of Thoracic Disease
2018;
10
(Suppl 13)
:S1534-S1546
.
(29 May 2018)
Oncogene-addicted non-small cell lung cancer and immunotherapy
Journal of Thoracic Disease
2018;
10
(Suppl 13)
:S1547-S1555
.
(29 May 2018)
A review of guidelines for lung cancer
Journal of Thoracic Disease
2018;
10
(Suppl 13)
:S1556-S1563
.
(29 May 2018)
Do immune checkpoint inhibitors need new studies methodology?
Journal of Thoracic Disease
2018;
10
(Suppl 13)
:S1564-S1580
.
(29 May 2018)
Next generation immune-checkpoints for cancer therapy
Journal of Thoracic Disease
2018;
10
(Suppl 13)
:S1581-S1601
.
(29 May 2018)
Vaccine and immune cell therapy in non-small cell lung cancer
Journal of Thoracic Disease
2018;
10
(Suppl 13)
:S1602-S1614
.
(29 May 2018)
Disclosure:
The supplement “Immunotherapy & Thoracic Cancers” was commissioned by the Editorial office, Journal of Thoracic Disease without any sponsorship or funding. Antonio Rossi and Silvia Novello served as the unpaid Guest Editors for the supplement.
